logo
logo

Willow Announces Second Program with Global Ingredient Manufacturer for Enzyme Development

Willow Announces Second Program with Global Ingredient Manufacturer for Enzyme Development

09/18/24, 11:07 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CA.svgcalgary
Industry
biotechnology
manufacturing
Type
partnership
Willow Biosciences Inc. announced a second program with a leading Active Pharmaceutical Ingredient manufacturer to develop an enzyme for manufacturing a large volume active pharmaceutical ingredient. The enzyme development is expected to enable commercial-scale production of the API in 2025.

Company Info

Company
Willow Biosciences
Location
calgary, alberta, canada
Additional Info
Willow develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Willow's FutureGrownTM and BioOxiTM platforms enable large-scale production with sustainability at its core.

Related People

Ch
Chris hidden
Copy AI Email to Clipboard
Send via Webmail
Go to AI Email Settings
hidden
hidden
Ah
Adriana hidden
Copy AI Email to Clipboard
Send via Webmail
Go to AI Email Settings
hidden
hidden